These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 10688401

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Inherited cystic diseases of the kidney.
    Choyke PL.
    Radiol Clin North Am; 1996 Sep; 34(5):925-46. PubMed ID: 8784390
    [Abstract] [Full Text] [Related]

  • 4. Lowering of Pkd1 expression is sufficient to cause polycystic kidney disease.
    Lantinga-van Leeuwen IS, Dauwerse JG, Baelde HJ, Leonhard WN, van de Wal A, Ward CJ, Verbeek S, Deruiter MC, Breuning MH, de Heer E, Peters DJ.
    Hum Mol Genet; 2004 Dec 15; 13(24):3069-77. PubMed ID: 15496422
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Polycystic kidney diseases: molecular genetics and counselling].
    Lespinasse J, Fourcade J, Schir F.
    Nephrol Ther; 2006 Jul 15; 2(3):120-6. PubMed ID: 16890136
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Variable renal disease progression in autosomal dominant polycystic kidney disease: a role for nitric oxide?
    Devuyst O.
    J Nephrol; 2003 Jul 15; 16(3):449-52. PubMed ID: 12832751
    [Abstract] [Full Text] [Related]

  • 10. Polycystic liver and kidney diseases.
    Tahvanainen E, Tahvanainen P, Kääriäinen H, Höckerstedt K.
    Ann Med; 2005 Jul 15; 37(8):546-55. PubMed ID: 16338757
    [Abstract] [Full Text] [Related]

  • 11. [Clinical approach in polycystic kidney disease with recurrent hematuria].
    Tepel M.
    Internist (Berl); 1997 Dec 15; 38(12):1239-41. PubMed ID: 9465332
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Increased activity of activator protein-1 transcription factor components ATF2, c-Jun, and c-Fos in human and mouse autosomal dominant polycystic kidney disease.
    Le NH, van der Wal A, van der Bent P, Lantinga-van Leeuwen IS, Breuning MH, van Dam H, de Heer E, Peters DJ.
    J Am Soc Nephrol; 2005 Sep 15; 16(9):2724-31. PubMed ID: 16049073
    [Abstract] [Full Text] [Related]

  • 17. Loss of polycystin-1 in human cyst-lining epithelia leads to ciliary dysfunction.
    Nauli SM, Rossetti S, Kolb RJ, Alenghat FJ, Consugar MB, Harris PC, Ingber DE, Loghman-Adham M, Zhou J.
    J Am Soc Nephrol; 2006 Apr 15; 17(4):1015-25. PubMed ID: 16565258
    [Abstract] [Full Text] [Related]

  • 18. New advances in evaluation and management of patients with polycystic liver disease.
    Arnold HL, Harrison SA.
    Am J Gastroenterol; 2005 Nov 15; 100(11):2569-82. PubMed ID: 16279915
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Intracranial aneurysms and autosomal dominant polycystic kidney disease: followup study by magnetic resonance angiography.
    Nakajima F, Shibahara N, Arai M, Gohji K, Ueda H, Katsuoka Y.
    J Urol; 2000 Aug 15; 164(2):311-3. PubMed ID: 10893572
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.